Shots:
- The US FDA has granted 510(k) clearance to Zipline Access Catheters to treat acute ischemic strokes
- Zipline improves delivery of a large (070) & superbore (088) aspiration catheter to enhance trackability & simplify neuro-interventional procedures for faster as well as more efficient stroke treatment. Zipline also optimizes clot removal & improves success rates with added support & easy navigation
- Additionally, Perfuze has secured $23.9M (€22M) from existing investors, incl. Earlybird, EQT Life Sciences, Seroba, & SV Health, to advance clinical and R&D activities, plus to support limited market release of Zipline & Millipede catheters, which are now launched in the US
Ref: BusinessWire | Image: Perfuze
Related News:- Ultromics’ EchoGo Amyloidosis Receives the US FDA’s Breakthrough Device Designation to Detect Cardiac Amyloidosis
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
